| Mouse PSCA Protein (LTP10467) |
| LTP10467 |
| 100ug |
|
$473 In stock |
| Gastric cancer is a deadly malignancy and is a prognostically unfavorable entity with restricted therapeutic strategies available. Prostate stem cell antigen (PSCA) is a glycosylphosphatidylinositol (GPI)-anchored cell surface protein widely expressed in bladder, prostate, and pancreatic cancers. Existing studies have thoroughly recognized the availability of utilizing anti-PSCA CAR-T cells in the treatment of metastatic prostate cancer and non-small-cell lung cancer. |
| Recombinant Mouse PSCA Protein is expressed from Expi293 with hFc tag at the N-terminal. It contains Leu21-Asn95. |
| PSCA |
| Mouse |
| P57096 |
| Leu21-Asn95 |
| The protein has a predicted MW of 34.5 kDa. Due to glycosylation, the protein migrates to 40-60 kDa based on the Tris-Bis PAGE result. |
| 0 |
| N-hFc |
| Expi293 |
| > 95% as determined by Tris-Bis PAGE; > 95% as determined by HPLC |
| Less than 1EU per ug by the LAL method. |
| Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as a protectant before lyophilization. |
| Reconstituted protein stable at -80 C for 12 months, 4 C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
| Shipped at ambient temperature. |
| Centrifuge tubes before opening. Reconstituting to a concentration of more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water. |
| |